liquiritigenin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhakuni, RS; Gaur, R; Verma, RK; Yadav, KS; Yadav, NP | 1 |
| Baek, SR; Kang, HE; Lee, JW; Lee, MG; Sohn, SI | 1 |
2 other study(ies) available for liquiritigenin and Alloxan Diabetes
| Article | Year |
|---|---|
In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin.
Topics: Animals; Body Weight; Chalcones; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Flavanones; Glycyrrhiza; Hypoglycemic Agents; Male; Mice; Phytotherapy; Plant Extracts | 2014 |
Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'-diphosphoglucuronic acid level.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Flavanones; Glucuronides; Injections, Intravenous; Intestinal Mucosa; Intestines; Liver; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Streptozocin; Uridine Diphosphate Glucuronic Acid | 2010 |